Afa Siting Jiaonang (阿伐斯汀胶囊)阿伐斯汀胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

阿伐斯汀是一种在国家药监局注册认定的药品。标注生产企业为重庆华邦制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司、重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司、重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 阿伐斯汀胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 重庆华邦制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司, 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司, 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 阿伐斯汀胶囊Recorded Chinese name: 阿伐斯汀胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 8mg*10s*2板8 mg × 10s × 2 blister boards

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20083406

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20083406

Manufacturer

Chinese legal name: 重庆华邦制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20083406

生产企业

重庆华邦制药有限公司(国产)

适应症

本品适用于过敏性鼻炎、过敏性皮肤疾病、慢性自发性荨麻疹、症状性皮肤划痕症、胆碱性荨麻疹、自发的后日性寒冷感冒荨麻疹、湿疹痕痒。

用法用量

口服:成人和12岁以上儿童每次8mg,每日2次。

不良反应

罕见嗜睡。

禁忌

已知对阿伐斯汀或吡咯吡胺(triprolidine)过敏的病人禁服。肾脏的排泄作用是消除阿伐斯汀的主要途径,在没有关于对肾损害患者使用的研究前,欣民立不被推荐用于明显地有肾功能损害的病人[肌酐清除率每分钟少于50毫升及血清肌酐量每公升多于150微克分子]。

注意事项

饮酒或服用其它中枢抑制药物时不要从事需保持高警觉性的工作。12岁以下儿童、孕妇、哺乳期妇女不宜使用。

贮藏

保存在摄氏25度以下。保持干燥及避光。

规格

8mg*10s*2板

证据Evidence

  • 批准文号: 国药准字H20083406
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.